Relationship of acute mania symptomatology to maintenance treatment response

Current Psychiatry Reports

Volumn 6, Issue 6, 2004, Pages 473-477

  Bowden, Charles L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; PLACEBO; SELENIUM; VALPROATE SEMISODIUM; ZINC; TRANQUILIZER;

APPETITE DISORDER; ATAXIA; BIPOLAR DISORDER; BIPOLAR MANIA; CHELATION; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL TOXICITY; HAIR LOSS; HOSPITALIZATION; HUMAN; LITHIUM BLOOD LEVEL; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; METABOLIC DISORDER; MONOTHERAPY; NEUROMUSCULAR DISEASE; PROGNOSIS; PSYCHOTHERAPY; RELAPSE; REVIEW; SCORING SYSTEM; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEIGHT GAIN; ACUTE DISEASE; CONTROLLED CLINICAL TRIAL; HEALTH STATUS; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ANTIMANIC AGENTS; BIPOLAR DISORDER; HEALTH STATUS; HUMANS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 16644378184     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-004-0013-0     Document Type: Review

References (27)

1. Gitlin MJ, Swendsen J, Heller TL, Hammen C: Relapse and impairment in bipolar disorder. Am J Psychiatry 1995, 152:1635-1640.
2. Chou JC, Tuma I, Sweeney EA: Treatment approaches for acute mania. Psychiatr Q 1993, 64:331-344.
3. Bowden CL, submitted.
4. Bowden CL, Calabrese JR, Sachs G, et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003, 60:392-400.
5. Tohen M, Chengappa KN, Suppes T, et al.: Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v mood stabiliser alone. Br J Psychiatry 2004, 184:337-345.
6. Goodwin GM, Bowden CL, Calabrese JR, et al.: A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004, 65:432-441.
7. Bowden CL, McElroy SL, Wozniak PJ, Collins MA: Relationship of Acute Mania Symptomatology to Maintenance Treatment Response. ACNP Abstracts of Panels and Posters. 2003.
8. Suppes T, Dennehy EB, Swann AC, et al.: Report of the Texas Consensus Conference panel on medication treatment of bipolar disorder in 2000. J Clin Psychiatry 2002, 63:288-299.
9. Wagner KD, Weller E, Carlson G, et al.: An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002, 41:1224-1230.
10. Sanger TM, Tohen M, Vieta E, et al.: Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord 2003, 73:155-161.
11. Keck PE, Meinhold JM, Prihoda TJ, et al.: Relation of serum valproate and lithium concentrations to efficacy and tolerability in maintenance therapy for bipolar disorder. 41st Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December, 2002.
12. Sachs G, Bowden CL, Calabrese JR, et al.: Lamotrigine: Evidence for mood stabilization in bipolar I depression. Am Coll Neuropsychopharmacology 2001.
13. Fagiolini A, Kupfer DJ, Houck PR, et al.: Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2002, 112.
14. Kusumakar V, Greene P, Earl N, et al.: Mood stabilization with lamotrigine in rapid cycling bipolar disorder: A double-blind placebo-controlled study. Eur Neuropsychopharmacology 2000, 10:S238.
15. Keller MB, Lavori PW, Kane JM, et al.: Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1992, 49:371-376.
16. Bowden CL: The Multiple Goals of Maintenance Treatment. Abstract presented at the American Psychiatric Association 2002 Annual Meeting, Philadelphia, PA, May 2002.
17. Keck Jr PE, Bowden CL, Meinhold JM, et al.: Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy. J Clin Psychiatry 2004.
18. Jacobsen FM: Low dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 1993, 54:229-234.
19. Zarate Jr CA, Tohen M, Narendran R, et al.: The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. J Clin Psychiatry 2000, 60:232-236.
20. Zajecka J, Weisler RSKW: Divalproex Sodium vs. Olanzapine for the Treatment of Mania in Bipolar Disorder. Presented at the 39th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.
21. Tohen M, Ketter TA, Zarate CA: Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003, 160:1263-1271.
22. Calabrese JR, Goodwin FK, Frye MA, Kusumakar V: Rash in multicenter trials of lamotrigine in mood disorder: Clinical relevance and management. J Clin Psychiatry 2002, 63:1012-1019.
23. Goodwin GM, Young AH: The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary. J Psychopharmacol 2003, 17:3-6.
24. Allison DB, Mentore JL, Heo M, et al.: Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999, 156:1686-1696.
25. Altshuler L, Suppes T, Black D, et al.: Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003, 160:1252-1262.
26. Colom F, Vieta E, Martinez-Aran A, et al.: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003, 60:402-407.
27. Miklowitz DJ, Simoneau TL, George EL, et al.: 1-Year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry 2000, 48:582-592.